Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-080918
Filing Date
2024-07-03
Accepted
2024-07-02 18:52:36
Documents
91
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K emma-20231231.htm   iXBRL 10-K 3777494
2 EX-10.20 emma-ex10_20.htm EX-10.20 34374
3 EX-10.23 emma-ex10_23.htm EX-10.23 17217
4 EX-10.41 emma-ex10_41.htm EX-10.41 28225
5 EX-21.1 emma-ex21_1.htm EX-21.1 6266
6 EX-23.1 emma-ex23_1.htm EX-23.1 6293
7 EX-31.1 emma-ex31_1.htm EX-31.1 13312
8 EX-31.2 emma-ex31_2.htm EX-31.2 10478
9 EX-32.1 emma-ex32_1.htm EX-32.1 10174
10 GRAPHIC img49175599_0.jpg GRAPHIC 104660
11 GRAPHIC img49175599_1.jpg GRAPHIC 40378
  Complete submission text file 0000950170-24-080918.txt   17048099

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT emma-20231231.xsd EX-101.SCH 2090903
94 EXTRACTED XBRL INSTANCE DOCUMENT emma-20231231_htm.xml XML 3615733
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

EIN.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35527 | Film No.: 241097680
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)